SR

Srinivasa Rao Malepati

Director Director DIN 00400542
DIN 00400542 First appointment Apr 2004 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2004
Shareholding value •••• Premium profile

About Srinivasa Rao Malepati

Data last updated:

Srinivasa Rao Malepati was a Director at Epikart Pharma Private Limited (2016–2024) and Director at Mendel Pharma Private Limited (2004–2009). The companies operate in Trading and Pharma.

DIN 00400542
Primary Designation Director
Industry Trading
First Appointment 22 Apr 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Epikart Pharma Private Limited U24233KA2016PTC085427
Director21 Jan 20162016₹11.2 Lakh (FY 2024)Active
Mendel Pharma Private Limited U24239TG2004PTC043103
Director22 Apr 20042004₹2.21 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Epikart Pharma Private Limited
Mendel Pharma Private Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Malepati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Malepati

Srinivasa Rao Malepati was first appointed on 22 Apr 2004 as Director at Mendel Pharma Private Limited. The most recent appointment on record is 21 Jan 2016 at Epikart Pharma Private Limited.

Srinivasa Rao Malepati held 2 earlier board appointments: Epikart Pharma Private Limited (Director, 21 Jan 2016 to 24 Feb 2024); Mendel Pharma Private Limited (Director, 22 Apr 2004 to 22 Mar 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available